Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Edwards

Showing results (101-110 of 158) with videos related to

Pageof 16
Sort By:
Gynecologic Oncology|March 1, 1988
Viral oncolysates in patients with advanced ovarian cancerR S Freedman, C L Edwards, J M Bowen, et al.
Gynecologic Oncology|August 1, 1995
Prolonged oral etoposide for refractory advanced uterine leiomyosarcomaP Chantarawiroj, D Tresukosol, A P Kudelka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
Effects of interleukin-1 alpha on carboplatin-induced thrombocytopenia in patients with recurrent ovarian cancerS Vadhan-Raj, A P Kudelka, L Garrison, et al.
Hybridoma|February 1, 1991
Development of a cell surface reacting human monoclonal antibody recognizing ovarian and certain other malignanciesR S Freedman, C G Ioannides, B Tomasovic, et al.
Gynecologic Oncology|March 1, 1991
Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamideT W Burke, C A Stringer, M Morris, et al.
Molecular Vision|April 4, 1998
A major cis activator of the IRBP gene contains CRX-binding and Ret-1/PCE-I elementsJ H Boatright, D E Borst, J W Peoples, et al.
Cancer|March 1, 1985
Prognosis of surgically determined complete responders in advanced ovarian cancerD M Gershenson, L J Copeland, J T Wharton, et al.
Gynecologic Oncology|November 1, 1990
Phase I evaluation of thio-TEPA in combination with cisplatin for advanced gynecologic malignanciesL G Sandles, R S Freedman, M N Raber, et al.
Cancer|January 15, 1985
Microscopic disease at second-look laparotomy in advanced ovarian cancerL J Copeland, D M Gershenson, J T Wharton, et al.
Anti-Cancer Drugs|July 1, 1996
Remission of refractory gestational trophoblastic disease with high-dose paclitaxelW Termrungruanglert, A P Kudelka, S Piamsomboon, et al.
Pageof 16

Showing results (101-110 of 158) with videos related to

Sort By:
Pageof 16
Gynecologic Oncology|March 1, 1988
Viral oncolysates in patients with advanced ovarian cancerR S Freedman, C L Edwards, J M Bowen, et al.
Gynecologic Oncology|August 1, 1995
Prolonged oral etoposide for refractory advanced uterine leiomyosarcomaP Chantarawiroj, D Tresukosol, A P Kudelka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
Effects of interleukin-1 alpha on carboplatin-induced thrombocytopenia in patients with recurrent ovarian cancerS Vadhan-Raj, A P Kudelka, L Garrison, et al.
Hybridoma|February 1, 1991
Development of a cell surface reacting human monoclonal antibody recognizing ovarian and certain other malignanciesR S Freedman, C G Ioannides, B Tomasovic, et al.
Gynecologic Oncology|March 1, 1991
Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamideT W Burke, C A Stringer, M Morris, et al.
Molecular Vision|April 4, 1998
A major cis activator of the IRBP gene contains CRX-binding and Ret-1/PCE-I elementsJ H Boatright, D E Borst, J W Peoples, et al.
Cancer|March 1, 1985
Prognosis of surgically determined complete responders in advanced ovarian cancerD M Gershenson, L J Copeland, J T Wharton, et al.
Gynecologic Oncology|November 1, 1990
Phase I evaluation of thio-TEPA in combination with cisplatin for advanced gynecologic malignanciesL G Sandles, R S Freedman, M N Raber, et al.
Cancer|January 15, 1985
Microscopic disease at second-look laparotomy in advanced ovarian cancerL J Copeland, D M Gershenson, J T Wharton, et al.
Anti-Cancer Drugs|July 1, 1996
Remission of refractory gestational trophoblastic disease with high-dose paclitaxelW Termrungruanglert, A P Kudelka, S Piamsomboon, et al.
Pageof 16